CELC vs GSK · $4.33B cap vs P/E 13, $103.31B cap
Celcuity LLC (CELC) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Celcuity LLC (CELC) is a biotechnology company listed on NASDAQ.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
CELC does not have a complete income-statement cache yet.
GSK does not have a complete income-statement cache yet.
CELC currently screens at market cap $4.33B. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the CELC and GSK stock pages for the full models.
Not investment advice.